May 15, 2019 7:30 am EDT Heat Biologics Reports First Quarter 2019 Results and Provides Corporate Update
May 06, 2019 7:00 am EDT Heat Biologics Lead Director to Present at the ChinaBio 2019 Conference in Shanghai
Apr 18, 2019 5:30 pm EDT Heat Biologics CEO to Present at the ThinkEquity Conference in New York City
Mar 21, 2019 7:00 am EDT Heat Biologics to Present at the Chinese Society for Clinical Oncology Conference on Immunotherapy
Mar 05, 2019 9:25 am EST Heat Biologics Lead Director to Chair Oncology Roundtable Discussion at WuXi Healthcare Forum in Shanghai
Feb 28, 2019 5:00 pm EST Heat Biologics Presents Interim Phase 2 Lung Cancer Data on HS-110 + Nivolumab at ASCO-SITC Clinical Immuno-Oncology Symposium
Jan 14, 2019 2:15 pm EST UPDATE: Heat Biologics Doses First Patient in New Cohort of its Expanded Phase 2 Trial of HS-110 in Combination with Merck's KEYTRUDA(R) in Non-Small Cell Lung Cancer Trial
Jan 14, 2019 8:00 am EST Heat Biologics Doses First Patient in New Cohort of its Expanded Phase 2 Trial of HS-110 in Combination with Merck's KEYTRUDA(R) in Non-Small Cell Lung Cancer Trial